Boehringer Ingelheim Introduction about the company

2.  Headquarters: Ingelheim am Rhein, Rhineland-Palatinate, Germany
 Founder: Albert Boehringer
 Founded: 1885, German
 Revenue: 14.7 billion EUR
 Our Vision: Value through Innovation is the central concept of our corporate
vision.

3. Board of Directors
Prof. Dr Andreas Barner
Chairman
Corporate Board Divisions Human
Resources, Research & Development and
Medicine
Dr Wolfgang Baiker
Corporate Board Divisions Biopharmaceuticals and
Operations
Dr Joachim Hasenmaier
Corporate Board Divisions Animal Health and Consumer
Healthcare (CHC)
Allan Hillgrove
Corporate Board Division Pharma Marketing and Sales

4. C. H. BOEHRINGER SOHN
 The pharmaceutical company Boehringer Ingelheim was founded in 1885 by
Albert Boehringer (1861-1939) in Ingelheim am Rhein.
 From its beginnings in 1885 when it employed just 28 people in Nieder-
Ingelheim, the company has since become a global enterprise.
 As part of research and development activities for innovative drugs, the
company focuses primarily on the therapeutic areas of cardiovascular disease,
respiratory diseases, diseases of the central nervous system, metabolic
diseases, virological diseases and oncology.

5. It comprised of a vertical oval with the
intertwined letters “CHBS” which
symbolize CH Boehringer and Sohn.
The company
logo until the
use 1924
First version of logo to
incorporated the central section of
the imperial places.
Next Logo
1
4
3
2
Company
LOGO

6. DESIGN ELEMENTS OF BOEHRINGER INGELHEIM LOGO
 The present Boehringer Ingelheim logo was originally designed in 1924. It was later
modified in 1962 to be reworked again in 1997 by Ole Schäfer of MetaDesign.
Color of the Boehringer Ingelheim Logo:
 The blue color in the Boehringer Ingelheim logo represents
excellence, strength and stability.

7. Discovery
 In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of
Nieder-Ingelheim. On 31 July, his company was included in the commercial register as “Albert
Boehringer, chem. Fabrik vom 1. Aug. 1885 ab”. This laid the foundation for the present-day
company Boehringer Ingelheim.
• He initially manufacture tartaric acid salts used by pharmacies and dyeing works. Demand for
this product surged in the first few years as fizzy lemonade and baking powder become popular.
• In 1893, Boehringer made the ground-breaking discovery that lactic acid can be produced in mass
quantities by means of bacteria, a discovery that saw the company pioneer large-scale "biotech"
production. This new process, combined with the high demand for lactic acid in the dyeing,
leather, textile and food industry, saw the company become the leading manufacturer of this agent.

8. Boehringer Ingelheim worldwide
 The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical
companies. Headquartered in Ingelheim, Germany, it operates globally with 142
affiliates and more than 47,400 employees.
America
•Argentina
•Brazil
•Canada
•Chile
•Colombia
•Ecuador
•Mexico
•Paraguay
•Peru
•USA
•Uruguay
•Venezuela
Africa, Asia, Australasia
•Armenia
•Australia
•Azerbaijan
•Bahrain
•China
•Egypt
•Ethiopia
•Georgia
•Ghana
•Hong Kong
•India
•Indonesia
•Iraq
•Israel
•Japan
•Jordan
•Kazakhstan
•Kenya
•Kirghizia
•Kosovo
•Kuwait
•Lebanon
•Libya
•Malawi
•Malaysia
•Mauritius
•Mongolia
•New Zealand
•Nigeria
•Oman
•Pakistan
•The Philippines
•Quatar
•Saudi Arabia
•Seychelles
•Singapore
•Somalia
•South Africa
•South Korea
•Sudan
•Syria
•Taiwan
•Tajikistan
•Tanzania
•Thailand
•Turkmenistan
•Uganda
•United Arab Emirates
•Uzbekistan
•Vietnam
•Yemen

9. Some more
 Europe
• Albania
• Austria
• Belarus
• Belgium
• Bosnia and Herzegovina
• Bulgaria
• Croatia
• Cyprus
• Moldavia
• Montenegro
•Czech Republic
•Denmark
•Estonia
•Finland
•France
•Germany
•Germany Headquarters
•Greece
•Hungary
•Ireland
•Italy
•Latvia
•Lithuania
•Republic of Macedonia
•Malta
•Portugal
•Romania
•Russia
•Serbia
•Slovakia
•Slovenia
•Spain
•Sweden
•Switzerland
•Turkey
•Ukraine
•United Kingdom
•The Netherlands
•Norway
•Poland

10. Actilyse (alteplase)
Aggrenox (dipyridamole/acetylsalicylic acid)
Aptivus (tipranavir)
Berodual (ipratropium bromide/fenoterol)
Combivent (ipratropium bromide/salbutamol)
Flomax (tamsulosin)
Gilotrif/Giotrif (afatinib)
Jentadueto/TrajentaDuo (linagliptin/metformin)
Metalyse (tenecteplase)
Prescription Medicine:
Products
Micardis (telmisartan)
Micardis Plus/Micardis HCT (telmisartan/hydrochlorothiazide)
Mirapex/Sifrol (pramipexole)
Mobic/Movalis (meloxicam)
Pradaxa (dabigatran etexilate)
Spiriva (tiotropium bromide)
Trajenta/Tradjenta (linagliptin)
Twynsta (telmisartan/amlodipine)
Viramune (nevirapine)

11. Antistax (red vine leaf extract)
Bisolvon (bromhexine)
Buscopan/Buscapina (hyoscine butylbromide)
Dulcolax (bisacodyl)
Zantac (ranitidine)—75 and 150 mg tablets; 300 mg
tablets, syrup and solution for injection are
manufactured by GlaxoSmithKline
Mucoangin/Mucosolvan (ambroxol)
Pharmaton (standardized ginseng extract, vitamins,
minerals, trace elements)
Silomat (dextromethorphan)
Thomapyrin (acetylsalicylic acid, paracetamol, caffeine)
CircoFLEX (porcine circovirus vaccine type 2,
killed Baculovirus vector)
Duramune (a line of pet vaccines)
Metacam (meloxicam)
MycoFLEX (Mycoplasma
hyopneumoniae bacterin)
Vetmedin (pimobendan)
Animal Health
Consumer Health Care

12. Year 2012 & 2013
Boehringer Ingelheim
group of companies 2013 2012 Change
Net sales
14,065 Million € 14,691 Million €
- 4 %
Net sales by region
Europe
30 % 29 %
Americas
46 % 47 %
Asia, Australasia, Africa
24 % 24 %

13. Thank you.